PASSAGE BIO INC shareholders Q2 2023

PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 55 filers reported holding PASSAGE BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

PASSAGE BIO INC shareholders Q2 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,959,769$4,668,6315.54%
New Leaf Venture Partners, L.L.C. 2,497,922$2,348,0472.02%
BML Capital Management, LLC 2,058,767$1,937,9171.74%
Lynx1 Capital Management LP 1,167,343$1,098,8200.72%
Acuitas Investments, LLC 418,173$393,6260.23%
Orbimed Advisors 10,124,576$9,530,2630.17%
Frazier Life Sciences Management, L.P. 1,850,000$1,741,4050.10%
TANG CAPITAL MANAGEMENT LLC 300,000$282,3900.04%
Marquette Asset Management, LLC 86,050$80,9990.02%
Annandale Capital, LLC 54,338$510.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 389,600$366,7300.01%
RBF Capital, LLC 142,807$134,4240.01%
CORNERCAP INVESTMENT COUNSEL INC 49,767$46,8460.01%
Pale Fire Capital SE 98,662$92,8710.01%
Weiss Multi-Strategy Advisers LLC 367,696$3460.01%
FIDUCIARY TRUST CO 115,000$108,2500.00%
ACADIAN ASSET MANAGEMENT LLC 578,806$5430.00%
Renaissance Technologies 979,095$9220.00%
TWO SIGMA INVESTMENTS, LP 259,854$244,6010.00%
TWO SIGMA ADVISERS, LP 247,700$233,1600.00%
External links

This page lists PASSAGE BIO INC's shareholders in Q2 2023. To view PASSAGE BIO INC's shareholder history, click here.